APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urticaria Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Urticaria Drug Industry Growth and Trends Forecast to 2032

31 December 202594 pages

Choose your research edition.

Industry ResearchUrticaria Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Urticaria Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Urticaria Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urticaria Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Urticaria Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Urticaria Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urticaria Drug include Akorn, Amneal Pharmaceuticals, Genentech, Taro Pharmaceutical Industries Novartis AG, Xolair, Pfizer, Johnson and Johnson Services and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Urticaria Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urticaria Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urticaria Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urticaria Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Urticaria Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urticaria Drug Market by Company

Akorn

Amneal Pharmaceuticals

Genentech

Taro Pharmaceutical Industries Novartis AG

Xolair

Pfizer

Johnson and Johnson Services

Teva Pharmaceutical Industries

Urticaria Drug Segment by Type

Acute Urticaria

Chronic Urticaria

Urticaria Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Others

Urticaria Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urticaria Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urticaria Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urticaria Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Urticaria Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Acute Urticaria Table 2. Major Company of Chronic Urticaria Table 3. Global Urticaria Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Urticaria Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Urticaria Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Urticaria Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Urticaria Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Urticaria Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Urticaria Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Urticaria Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Urticaria Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Urticaria Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Urticaria Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Urticaria Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Urticaria Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Urticaria Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Urticaria Drug Industry Trends Table 25. Urticaria Drug Industry Drivers Table 26. Urticaria Drug Industry Opportunities and Challenges Table 27. Urticaria Drug Industry Restraints Table 28. Global Urticaria Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Urticaria Drug Revenue Market Share by Company (2021-2026) Table 30. Global Urticaria Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Urticaria Drug Sales Share by Company (2021-2026) Table 32. Global Urticaria Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Urticaria Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Urticaria Drug Major Company Production Sites and Headquarters Table 35. Global Urticaria Drug Company, Product Type & Application Table 36. Global Urticaria Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Urticaria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Urticaria Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Urticaria Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Urticaria Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Urticaria Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Urticaria Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Urticaria Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Urticaria Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Urticaria Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Urticaria Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Urticaria Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Urticaria Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Urticaria Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Urticaria Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Urticaria Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Urticaria Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Urticaria Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Urticaria Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Urticaria Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Urticaria Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Urticaria Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Urticaria Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Urticaria Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Urticaria Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Akorn Company Information Table 72. Akorn Business Overview Table 73. Akorn Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Akorn Urticaria Drug Product Portfolio Table 75. Akorn Recent Development Table 76. Amneal Pharmaceuticals Company Information Table 77. Amneal Pharmaceuticals Business Overview Table 78. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amneal Pharmaceuticals Urticaria Drug Product Portfolio Table 80. Amneal Pharmaceuticals Recent Development Table 81. Genentech Company Information Table 82. Genentech Business Overview Table 83. Genentech Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Genentech Urticaria Drug Product Portfolio Table 85. Genentech Recent Development Table 86. Taro Pharmaceutical Industries Novartis AG Company Information Table 87. Taro Pharmaceutical Industries Novartis AG Business Overview Table 88. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio Table 90. Taro Pharmaceutical Industries Novartis AG Recent Development Table 91. Xolair Company Information Table 92. Xolair Business Overview Table 93. Xolair Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Xolair Urticaria Drug Product Portfolio Table 95. Xolair Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Urticaria Drug Product Portfolio Table 100. Pfizer Recent Development Table 101. Johnson and Johnson Services Company Information Table 102. Johnson and Johnson Services Business Overview Table 103. Johnson and Johnson Services Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Johnson and Johnson Services Urticaria Drug Product Portfolio Table 105. Johnson and Johnson Services Recent Development Table 106. Teva Pharmaceutical Industries Company Information Table 107. Teva Pharmaceutical Industries Business Overview Table 108. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Teva Pharmaceutical Industries Urticaria Drug Product Portfolio Table 110. Teva Pharmaceutical Industries Recent Development Table 111. North America Urticaria Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 113. North America Urticaria Drug Sales Market Share by Country (2021-2026) Table 114. North America Urticaria Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Urticaria Drug Sales Market Share Forecast by Country (2027-2032) Table 116. North America Urticaria Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Urticaria Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Urticaria Drug Market Share by Country (2021-2026) Table 119. North America Urticaria Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Urticaria Drug Market Share Forecast by Country (2027-2032) Table 121. Europe Urticaria Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 123. Europe Urticaria Drug Sales Market Share by Country (2021-2026) Table 124. Europe Urticaria Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Urticaria Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Urticaria Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Urticaria Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Urticaria Drug Market Share by Country (2021-2026) Table 129. Europe Urticaria Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Urticaria Drug Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Urticaria Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Urticaria Drug Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Urticaria Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Urticaria Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Urticaria Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Urticaria Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Urticaria Drug Market Share by Country (2021-2026) Table 139. Asia-Pacific Urticaria Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Urticaria Drug Market Share Forecast by Country (2027-2032) Table 141. Latin America Urticaria Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 143. Latin America Urticaria Drug Sales Market Share by Country (2021-2026) Table 144. Latin America Urticaria Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Urticaria Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Urticaria Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Urticaria Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Urticaria Drug Market Share by Country (2021-2026) Table 149. Latin America Urticaria Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Urticaria Drug Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Urticaria Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Urticaria Drug Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Urticaria Drug Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Urticaria Drug Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Urticaria Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Urticaria Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Urticaria Drug Market Share by Country (2021-2026) Table 159. Middle East and Africa Urticaria Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Urticaria Drug Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Urticaria Drug Distributors List Table 164. Urticaria Drug Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Urticaria Drug Image Figure 2. Global Urticaria Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urticaria Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Urticaria Drug Sales (2021-2032) & (K Units) Figure 5. Acute Urticaria Image Figure 6. Global Acute Urticaria Sales YoY Growth (2021-2032) & (K Units) Figure 7. Chronic Urticaria Image Figure 8. Global Chronic Urticaria Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Urticaria Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Urticaria Drug Market Share by Type 2025 VS 2032 Figure 11. North America Urticaria Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Urticaria Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Urticaria Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Urticaria Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Urticaria Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Urticaria Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Urticaria Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Urticaria Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Urticaria Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Urticaria Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Urticaria Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Urticaria Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Urticaria Drug Market Share by Application 2025 VS 2032 Figure 33. North America Urticaria Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Urticaria Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Urticaria Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Urticaria Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Urticaria Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Urticaria Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Urticaria Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Urticaria Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Urticaria Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Urticaria Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Urticaria Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Urticaria Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Urticaria Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Urticaria Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Urticaria Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Urticaria Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Urticaria Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Urticaria Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Urticaria Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Urticaria Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Urticaria Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Urticaria Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Urticaria Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Urticaria Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Urticaria Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Urticaria Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Urticaria Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Urticaria
  • Chronic Urticaria
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Akorn
  • Amneal Pharmaceuticals
  • Genentech
  • Taro Pharmaceutical Industries Novartis AG
  • Xolair
  • Pfizer
  • Johnson and Johnson Services
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urticaria Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Urticaria Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Urticaria Drug Market by Type
  6. 1.3.1 Acute Urticaria
  7. 1.3.2 Chronic Urticaria
  8. 1.4 Global Urticaria Drug Market Size by Type
  9. 1.4.1 Global Urticaria Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Urticaria Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Urticaria Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Urticaria Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Urticaria Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Urticaria Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Urticaria Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Urticaria Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Urticaria Drug Industry Trends
  2. 2.2 Urticaria Drug Industry Drivers
  3. 2.3 Urticaria Drug Industry Opportunities and Challenges
  4. 2.4 Urticaria Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Urticaria Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Urticaria Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Urticaria Drug Price (2021-2026)
  4. 3.4 Global Urticaria Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urticaria Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Urticaria Drug Company, Product Type & Application
  7. 3.7 Global Urticaria Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urticaria Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urticaria Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urticaria Drug Tier 1, Tier 2, and Tier 3
4 Urticaria Drug Regional Status and Outlook
  1. 4.1 Global Urticaria Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Urticaria Drug Historic Market Size by Region
  3. 4.2.1 Global Urticaria Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Urticaria Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Urticaria Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Urticaria Drug Forecasted Market Size by Region
  7. 4.3.1 Global Urticaria Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Urticaria Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Urticaria Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Urticaria Drug by Application
  1. 5.1 Urticaria Drug Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Urticaria Drug Market Size by Application
  7. 5.2.1 Global Urticaria Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Urticaria Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Urticaria Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Urticaria Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Urticaria Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Urticaria Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Urticaria Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Urticaria Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akorn
  2. 6.1.1 Akorn Company Information
  3. 6.1.2 Akorn Business Overview
  4. 6.1.3 Akorn Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akorn Urticaria Drug Product Portfolio
  6. 6.1.5 Akorn Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Urticaria Drug Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 Genentech
  14. 6.3.1 Genentech Company Information
  15. 6.3.2 Genentech Business Overview
  16. 6.3.3 Genentech Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genentech Urticaria Drug Product Portfolio
  18. 6.3.5 Genentech Recent Developments
  19. 6.4 Taro Pharmaceutical Industries Novartis AG
  20. 6.4.1 Taro Pharmaceutical Industries Novartis AG Company Information
  21. 6.4.2 Taro Pharmaceutical Industries Novartis AG Business Overview
  22. 6.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio
  24. 6.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments
  25. 6.5 Xolair
  26. 6.5.1 Xolair Company Information
  27. 6.5.2 Xolair Business Overview
  28. 6.5.3 Xolair Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Xolair Urticaria Drug Product Portfolio
  30. 6.5.5 Xolair Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Urticaria Drug Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Johnson and Johnson Services
  38. 6.7.1 Johnson and Johnson Services Company Information
  39. 6.7.2 Johnson and Johnson Services Business Overview
  40. 6.7.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Johnson and Johnson Services Urticaria Drug Product Portfolio
  42. 6.7.5 Johnson and Johnson Services Recent Developments
  43. 6.8 Teva Pharmaceutical Industries
  44. 6.8.1 Teva Pharmaceutical Industries Company Information
  45. 6.8.2 Teva Pharmaceutical Industries Business Overview
  46. 6.8.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Industries Urticaria Drug Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
  1. 7.1 North America Urticaria Drug Sales by Country
  2. 7.1.1 North America Urticaria Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Urticaria Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Urticaria Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Urticaria Drug Market Size by Country
  6. 7.2.1 North America Urticaria Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Urticaria Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Urticaria Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Urticaria Drug Sales by Country
  2. 8.1.1 Europe Urticaria Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Urticaria Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Urticaria Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Urticaria Drug Market Size by Country
  6. 8.2.1 Europe Urticaria Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Urticaria Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Urticaria Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Urticaria Drug Sales by Country
  2. 9.1.1 Asia-Pacific Urticaria Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Urticaria Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Urticaria Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Urticaria Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Urticaria Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Urticaria Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Urticaria Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Urticaria Drug Sales by Country
  2. 10.1.1 South America Urticaria Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Urticaria Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Urticaria Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Urticaria Drug Market Size by Country
  6. 10.2.1 South America Urticaria Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Urticaria Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Urticaria Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Urticaria Drug Sales by Country
  2. 11.1.1 Middle East and Africa Urticaria Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Urticaria Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Urticaria Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Urticaria Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Urticaria Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Urticaria Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Urticaria Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Urticaria Drug Value Chain Analysis
  2. 12.1.1 Urticaria Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Urticaria Drug Production Mode & Process
  7. 12.2 Urticaria Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Urticaria Drug Distributors
  10. 12.2.3 Urticaria Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst